Glialign Limited (10180388) is a private limited with share capital incorporated on 14/05/2016 (9 years old) and registered in london, W1T4TJ. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Glialign limited is a new tissue engineering/ regenerative medicine company based in university college london school of pharmacy, brunswick square, london wc1n 1ax. the company's focus is on novel cells/materials constructs for neural tissue repair. glialign is funded by the ucl tech fund, uk innov...
Termination Director Company With Name Termination Date
Category:Officers
Date:06-03-2024
Accounts With Accounts Type Micro Entity
Category:Accounts
Date:26-02-2024
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:30-05-2023
Accounts With Accounts Type Micro Entity
Category:Accounts
Date:28-02-2023
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:26-05-2022
Accounts With Accounts Type Micro Entity
Category:Accounts
Date:28-02-2022
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:17-12-2021
Accounts With Accounts Type Micro Entity
Category:Accounts
Date:26-05-2021
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:26-05-2021
Confirmation Statement With Updates
Category:Confirmation Statement
Date:28-05-2020
Accounts With Accounts Type Micro Entity
Category:Accounts
Date:25-02-2020
Capital Allotment Shares
Category:Capital
Date:13-08-2019
Confirmation Statement With Updates
Category:Confirmation Statement
Date:29-05-2019
Accounts With Accounts Type Micro Entity
Category:Accounts
Date:28-02-2019
Notification Of A Person With Significant Control
Category:Persons With Significant Control
Date:30-05-2018
Confirmation Statement With Updates
Category:Confirmation Statement
Date:29-05-2018
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:29-05-2018
Capital Allotment Shares
Category:Capital
Date:17-05-2018
Capital Allotment Shares
Category:Capital
Date:09-05-2018
Capital Alter Shares Subdivision
Category:Capital
Date:09-05-2018
Resolution
Category:Resolution
Date:09-05-2018
Resolution
Category:Resolution
Date:02-05-2018
Accounts Amended With Accounts Type Dormant
Category:Accounts
Date:15-03-2018
Accounts With Accounts Type Dormant
Category:Accounts
Date:13-01-2018
Appoint Person Director Company With Name Date
Category:Officers
Date:24-11-2017
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:03-07-2017
Confirmation Statement With Updates
Category:Confirmation Statement
Date:16-05-2017
Incorporation Company
Category:Incorporation
Date:14-05-2016
Innovate Grants
1
This company received a grant of £100001.0 for Commercial Feasibility Of Engineered Neural Tissue. The project started on 01/01/2018 and ended on 31/12/2018.